Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Progabide‐Induced Changes in Carbamazepine Metabolism
Nina M. Graves
, Robin H. Fuerst
,
James C. Cloyd
, Richard C. Brundage
, Timothy E. Welty
,
Ilo E. Leppik
Experimental and Clinical Pharmacology
Research output
:
Contribution to journal
›
Article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Progabide‐Induced Changes in Carbamazepine Metabolism'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Carbamazepine
100%
Carbamazepine Metabolism
100%
Carbamazepine-10,11-epoxide
47%
Placebo
14%
Valproate
14%
Epoxides
9%
Active Treatment
9%
Traitement
9%
Calcul
9%
Efficacy Trial
4%
Safety Trial
4%
Metabolism
4%
Serum Concentration
4%
Serial Measurements
4%
Treatment Duration
4%
Protein Binding Site
4%
Placebo Treatment
4%
Binding Inhibition
4%
First Dose
4%
Rapport
4%
Mesure
4%
Pacientes
4%
Carbamazepin
4%
11-epoxide
4%
Seguridad
4%
Behandlung
4%
Reducciones
4%
Medicine and Dentistry
Carbamazepine
100%
Carbamazepine 10,11 Oxide
57%
Progabide
52%
Placebo
19%
Sodium Valproate
14%
Active Treatment
9%
Protein Binding
4%
Binding Site
4%
Epoxide
4%